Navigation Links
Valeant Announces Pricing of Senior Notes
Date:3/3/2011

MISSISSAUGA, Ontario, March 3, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (the "Company") announced today that Valeant Pharmaceuticals International ("Valeant"), its wholly owned indirect subsidiary, has priced its previously announced offering of senior unsecured notes, which consists of $950 million aggregate principal amount of 6.500% Senior Notes due 2016 and $550 million aggregate principal amount of 7.250% Senior Notes due 2022 (collectively, the "Notes"). The offering is expected to close on or about March 8, 2011.

The Notes will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), or any state securities law and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act and applicable state securities laws. The Notes will be offered in the United States only to qualified institutional buyers under Rule 144A of the Securities Act and outside the United States under Regulation S of the Securities Act. The Notes have not been and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the securities in Canada will be made on a basis which is exempt from the prospectus requirements of such securities laws.

The Notes will be guaranteed by the Company and each of the Company's subsidiaries (other than Valeant) that is a guarantor under Valeant's other senior notes.

Valeant intends to use the net proceeds from the offering of the Notes to prepay the amounts outstanding under its term loan A facility (and cancel the undrawn senior secured revolving credit facility); to fund the $275 million repurchase of shares of the Company's common shares from ValueAct Capital Master Fund, L.P. pursuant to the terms of a recently announ
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valeant to Acquire Polish Products
2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
8. Valeant Announces Pricing of Senior Notes
9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... -- A drug commonly taken to prevent seizures in epilepsy ... (MS), according to a study released today that will be ... in Washington, DC , April 18 to ... MS experience at some point in their life a condition ... from the eye to the brain gets inflamed," said study ...
(Date:4/16/2015)... , April 16, 2015  Alexza Pharmaceuticals, Inc. (Nasdaq: ... ended March 31, 2015 on Wednesday, May 6, 2015, following ... also host an investor conference call and live webcast on ... a company update and discuss the financial results.  ... www.alexza.com , under the "Investors" link.  Please log onto ...
(Date:4/16/2015)... DUBLIN , April 16, 2015 ... specialty biopharmaceutical company, today announced that it has ... purchase price of approximately $2.3 billion. The Ikaria ... and expands its reach into neonatal critical care ... vital treatment option for a highly vulnerable patient ...
Breaking Medicine Technology:Epilepsy Drug May Preserve Eyesight for People with MS 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3Mallinckrodt Completes Acquisition Of Ikaria 2Mallinckrodt Completes Acquisition Of Ikaria 3Mallinckrodt Completes Acquisition Of Ikaria 4Mallinckrodt Completes Acquisition Of Ikaria 5
... Jan. 11, 2011 Reportlinker.com announces that a ... catalogue: Johnson & Johnson: PharmaVitae ... IntroductionThis analysis examines the historical ... the prescription pharmaceutical sector. The profile encompasses global ...
... Reportlinker.com announces that a new market research ... Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile ... IntroductionThis analysis examines the historical ... pharmaceutical sector. The profile encompasses global company strategy, ...
Cached Medicine Technology:Reportlinker Adds Johnson & Johnson: PharmaVitae Profile 2Reportlinker Adds Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile 2
(Date:4/17/2015)... York, NY (PRWEB) April 18, 2015 ... at their facility, rounding out their list of diagnostic ... care center for patients on the Upper East Side ... and running at full capacity. The addition of PET-CT, ... gives their physicians the ability to work with patients ...
(Date:4/17/2015)... Tampa, Florida (PRWEB) April 17, 2015 ... Term Acute Care and Florida Hospital Carrollwood were all ... Hospital Wesley Chapel, located in Pasco County, is ranked ... Bay Times workplaces survey, which was conducted in partnership ... is an 83 all-private bed hospital that opened in ...
(Date:4/17/2015)... San Jose, CA (PRWEB) April 17, 2015 ... of life insurance protection without modifications can now use ... are now general life insurance policy rates that are ... . , The standard plans that are offered are ... for adults aged 18 to 79. There are now ...
(Date:4/17/2015)... 17, 2015 At the end of ... and the “Salute to the Oscars” in the Stardust ... Hotel, overlooking the impressive Los Angeles skyline. These events ... Debbie Durkin, LA’s leading producer of sustainable product placement ... the world’s premier providers of eco-friendly and socially conscious ...
(Date:4/17/2015)... Organic Valley, the nation’s largest cooperative ... International Year of Soils by “Cycling for Sustainability” through ... employees will travel 215 miles from Auburn, California, to ... about the impact of agriculture on water and soil ... Maine, Wisconsin, Oregon, and Washington state, the cyclists have ...
Breaking Medicine News(10 mins):Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 3
... Choice Act, Spark Major Drive for Healthcare Union Organizing, ... Calif. and WASHINGTON, March 19 In ... pass the Employee Free Choice Act and rapidly promote ... International Union and the California Nurses Association/National ...
... Health Provisions , ... Newport Beach, CA. (PRWEB) March ... benefits management services , today released a summary of the ... face of the significant changes from Barack Obama’s new administration, Secova ...
... and homeopathic alternative for reducing the symptoms related ... (ADHD) without a prescription and without negative side ... medication use in children ages 5 to 19 ... researchers from the Saint Louis University School of ...
... March 19 The 2009 Frost & ... Product Quality Leadership Award is presented to ... Uncompromising quality maintenance, together with exceptional customer ... success. (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...
... is National Brain Injury Awareness MonthWHEATON, Ill., March 18 ... 3.8 million individuals in the U.S. each year according to ... a type of traumatic brain injury (TBI) caused by a ... mild to severe. It is important to note that even ...
... playsPHOENIX, March 18 Gold Canyon, a leader ... Candle Game to benefit the Prayer Child Foundation. For every ... will donate 10 cents to help children facing physical and ... http://thecandlegame.com and through Facebook on Gold Canyon,s official ...
Cached Medicine News:Health News:SEIU, CNA/NNOC Announce Major Accord 2Health News:SEIU, CNA/NNOC Announce Major Accord 3Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 2Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 3Health News:ADD-care -- A Natural, Homeopathic Alternative Reducing Symptoms Related to Attention Deficit Disorder 2Health News:ADD-care -- A Natural, Homeopathic Alternative Reducing Symptoms Related to Attention Deficit Disorder 3Health News:Frost & Sullivan Product Quality Accolade for KIBI Software Solutions 2Health News:Frost & Sullivan Product Quality Accolade for KIBI Software Solutions 3Health News:Sports Concussions: Common and Preventable 2Health News:Gold Canyon Ignites Hope With Online Charity Candle Game 2
Adjustable speed vortex with inter-changeable heads , 110 V...
Inquire...
Adjustable speed vortex with inter-changeable heads, 110 V...
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
Medicine Products: